The Dynamic Duo: GLP-1 Receptor Agonists and SGLT2 Inhibitors [pros and cons to diet pills]

The Dynamic Duo: GLP-1 Receptor Agonists and SGLT2 Inhibitors [pros and cons to diet pills]

| 1h 28m 28s | Video has closed captioning.

Presentation by Robert Busch, MD 1. Identify appropriate pharmacologic treatment options for individualized T2DM management using guideline- and trial-based evidence and accounting for patient presentation. How do you tailor therapy? 2. Explain the new indications for commonly used diabetes medications (SGLT-2’s, GLP’s) 3. Discuss new and emerging therapies for the management of T2DM Recorded live, April 6, 2024 as part of the Richard C. Staab, DO Memorial Symposium. Presented by Oklahoma State Medical Center Department of Internal Medicine in partnership with the Osteopathic Founders Foundation and Saint Francis Health System. This recording is viewable for reference and educational purposes only, and does not qualify for CME credit. For upcoming CME opportunities, please visit